+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anti-Snoring Treatment Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805740
The global anti-snoring treatment market size attained a value of USD 1.26 billion in 2022. The market is anticipated to grow at a CAGR of 7.5% during the forecast period of 2023-2031 to attain a value of USD 2.42 billion by 2031.

Anti-Snoring Treatment Market: Introduction

Anti-snoring treatments are interventions aimed at reducing or eliminating the occurrence of snoring, a common condition where a person makes a loud or harsh sound during sleep. Snoring is caused by the vibration of respiratory structures due to obstructed air movement during breathing. While snoring itself is generally not harmful, it can disrupt the sleep of others and, in some cases, indicate a more serious health condition known as obstructive sleep apnea.

There are various types of anti-snoring treatments, ranging from lifestyle changes, over-the-counter products, to medical procedures. Lifestyle changes may include weight loss, regular exercise, avoiding alcohol and sedatives, and altering sleep positions. Over-the-counter products like nasal strips, throat sprays, and special pillows can also be effective. For more severe cases, medical devices such as continuous positive airway pressure (CPAP) machines, oral appliances, or even surgery might be recommended.

The benefits of anti-snoring treatments are manifold:
  • Improved Sleep Quality: The primary benefit is improved sleep quality, not just for the person who snores, but also for those around them. Better sleep can lead to increased energy levels, improved mood, and better overall health
  • Reduced Health Risks: Regular, heavy snoring is often a sign of sleep apnea, a condition that, if left untreated, can lead to serious health issues such as heart disease, stroke, and high blood pressure. Anti-snoring treatments can help manage these risks
  • Enhanced Daytime Functioning: Poor sleep quality can lead to daytime fatigue, decreased concentration, and lower productivity. By improving sleep, anti-snoring treatments can enhance daytime functioning and overall quality of life
  • Improved Relationships: Snoring can strain relationships, particularly in shared sleeping arrangements. By reducing or eliminating snoring, these treatments can help foster harmony in relationships
Despite the wide range of anti-snoring treatments available, it is crucial to consult a healthcare professional before starting any treatment, as they can help identify the underlying cause of snoring and recommend the most effective approach.

Anti-Snoring Treatment Market Segmentations

The market can be categorised into device type, surgery type, distribution channel, and region.

Market Breakup by Device Type

Oral Appliances

  • Mandibular Advancement Devices (MAD)
  • Tongue-Retaining Devices (TRDS)
  • Others

Nasal Devices

  • Nasal Dilators (Nasal Strip)
  • Septal Stimulators
  • Others

Tongue Stabilizing Devices (TSDs)

  • Chin Straps
  • Position Control Devices
  • Expiratory Positive Airway Pressure (EPAP) Therapy Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Others

Market Breakup by Surgery Type

  • Uvulopalatopharyngoplasty (UPPP)
  • Laser-Assisted Uvulopalatoplasty (LAUP)
  • Radiofrequency Ablation (Somnoplasty)
  • Pillar Procedure
  • Injection Snoreplasty/Sclerotherapy
  • Palatal Stiffening Procedures
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

Anti-Snoring Treatment Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Anti-Snoring Treatment Market Scenario

The most common treatments for snoring include lifestyle changes, anti-snoring devices, medications, and surgical procedures. Lifestyle changes such as losing weight, quitting smoking, and reducing alcohol consumption have been the first line of action for many. However, these methods require a high degree of personal commitment and don't always yield immediate results, which has led to a surge in the demand for quicker and more effective solutions.

Among the anti-snoring devices, mandibular advancement devices (MADs) and tongue stabilizing devices (TSDs) have been particularly popular. These devices work by repositioning the jaw or the tongue to increase the size of the upper airway, thus reducing the air resistance that leads to snoring. Continuous Positive Airway Pressure (CPAP) machines are also commonly used, particularly for more severe cases of snoring and obstructive sleep apnea.

The global anti-snoring devices market has been seeing numerous innovations, with companies investing in research and development to create more comfortable and efficient products. These devices are now more customizable, adjustable, and user-friendly than ever before. Moreover, the emergence of smart technology has opened up new possibilities for the market, with smart snoring solutions that can monitor sleep patterns and automatically adjust settings for optimal effectiveness.

However, despite the advancements in anti-snoring devices, there is still a significant portion of the market that opts for medicinal or surgical solutions. Over-the-counter and prescription medications can help to reduce snoring in some cases, especially when it's caused by nasal congestion or allergies. Surgical treatments, on the other hand, are typically recommended for those with severe snoring or sleep apnea who have not responded to other treatments. These procedures can involve tissue removal, tissue shrinkage, or implants.

The anti-snoring treatment market has also been buoyed by the increasing adoption of telemedicine and digital health platforms. These platforms allow patients to receive professional medical advice and treatment from the comfort of their own homes, which has proven particularly valuable amidst the ongoing COVID-19 pandemic.

In terms of geography, North America has been the largest market for anti-snoring treatments, followed by Europe. This is largely due to high awareness levels, advanced healthcare infrastructure, and higher disposable income. However, the Asia Pacific region is expected to experience significant growth in the coming years, driven by a rising middle-class population, increasing healthcare expenditure, and growing awareness of sleep disorders.

Overall, the anti-snoring treatment market is likely to continue its growth trajectory in the foreseeable future, driven by increasing global awareness of sleep disorders, technological advancements in treatment devices, and the shift towards telemedicine.

Key Players in the Global Anti-Snoring Treatment Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the anti-snoring treatment market are as follows:
  • Apnea Sciences Corporation
  • GlaxoSmithKline plc
  • MEDiTAS Ltd
  • SomnoMed, Inc
  • The Pure Sleep Company
  • Foundation Care
  • Tomed Dr. Toussaint GmbH
  • Philips Healthcare
  • Airway Management Inc
  • Fisher And Paykel Healthcare

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Anti-Snoring Treatment Market Overview
3.1 Global Anti-Snoring Treatment Market Historical Value (2016-2022)
3.2 Global Anti-Snoring Treatment Market Forecast Value (2023-2031)
4 Global Anti-Snoring Treatment Market Landscape
4.1 Global Anti-Snoring Treatment Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Anti-Snoring Treatment Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Surgery Type
4.2.3 Analysis by Distribution Channel
5 Global Anti-Snoring Treatment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Anti-Snoring Treatment Market Segmentation
6.1 Global Anti-Snoring Treatment Market by Device Type
6.1.1 Market Overview
6.1.2 Oral Appliances Mandibular Advancement Devices (MAD) Tongue-Retaining Devices (TRDs) Others
6.1.3 Nasal Devices External Nasal Dilators (Nasal Strip) Septal Stimulators Others
6.1.4 Tongue Stabilizing Devices (TSDs)
6.1.5 Position Control Devices
6.1.6 Expiratory Positive Airway Pressure (EPAP) Therapy Devices
6.1.7 Continuous Positive Airway Pressure (CPAP) Devices
6.1.8 Others
6.2 Global Anti-Snoring Treatment Market by Surgery Type
6.2.1 Market Overview
6.2.2 Uvulopalatopharyngoplasty
6.2.3 Laser-Assisted Uvulopalatoplasty
6.2.4 Tonsillectomy
6.2.5 Radiofrequency Palatoplasty
6.2.6 Pillar Procedure
6.2.7 Injection Snoreplasty/Sclerotherapy
6.2.8 Palatal Stiffening Procedures
6.2.9 Others
6.3 Global Anti-Snoring Treatment Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacies
6.3.3 Retail Pharmacies
6.3.4 Online
6.3.5 Others
6.4 Global Anti-Snoring Treatment Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Anti-Snoring Treatment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Anti-Snoring Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Anti-Snoring Treatment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Anti-Snoring Treatment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Anti-Snoring Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Apnea Sciences Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 GlaxoSmithKline plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 MEDiTAS Ltd
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 SomnoMed, Inc
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 The Pure Sleep Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Foundation Care
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Tomed Dr. Toussaint GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Philips Healthcare
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Airway Management Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Fisher And Paykel Healthcare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Anti-Snoring Treatment Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Apnea Sciences Corporation
  • GlaxoSmithKline plc
  • MEDiTAS Ltd
  • SomnoMed Inc
  • The Pure Sleep Company
  • Foundation Care
  • Tomed Dr. Toussaint GmbH
  • Philips Healthcare
  • Airway Management Inc.
  • Fisher And Paykel Healthcare



Table Information